Acute Hepatitis C Clinical Trial
Official title:
Treatment of Recently Acquired Hepatitis C Virus Infection
To determine whether response guided treatment with pegylated interferon +/- ribavirin is effective for the treatment of recently acquired hepatitis C infection. Response guided treatment is when the length of treatment is determined by how quickly you respond to the treatment.
A prospective longitudinal study of natural history and treatment outcomes following response guided treatment of recent hepatitis C infection. ;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00755950 -
Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
|
Phase 2/Phase 3 | |
| Completed |
NCT02309918 -
HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection
|
Phase 2 | |
| Completed |
NCT02886624 -
Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4
|
Phase 2 | |
| Completed |
NCT03818308 -
Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir
|
Phase 2 | |
| Recruiting |
NCT01289652 -
The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
|
N/A | |
| Completed |
NCT00959166 -
To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection
|
N/A | |
| Completed |
NCT02377856 -
Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection
|
Phase 4 | |
| Completed |
NCT02600325 -
Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV
|
Phase 3 | |
| Completed |
NCT02000063 -
Australian Trial in Acute Hepatitis C Recall Study
|
N/A |